On September 5, 2022, it was announced that the Interterritorial Council for the Spanish National Health System (CISNS) approved the distribution of funds to the Autonomous Communities for the fight against cancer. The aim is to boost the screening programs for colorectal and cervical cancer. It was outlined that these screenings are essential for the early detection of these pathologies in the target population. The total amount of funds to be distributed is €12 million, €6 million for 2022, and another €6 million for 2023.
As an example, the target population for colorectal cancer screening currently includes men and women aged 50 to 69 years. The screening test is a fecal occult blood test, and the interval between screening tests is two years. In addition to the screening program, in the case of people who meet the criteria of high personal risk or risk of familial or hereditary cancer, the assessment of the individual risk and follow-up is carried out through specific action protocols.
The target population for the cervical cancer screening program are women aged 25 to 65 years. In women aged 25 to 34 years the primary screening test is cytology, which is carried out every three years. In women aged 35 to 65 years, the determination of high-risk human papillomavirus (HPV) is used; further strategy depends on the test results. In addition to the screening program, in the case of women who meet the criteria of high personal risk or risk of familial or hereditary cancer, the assessment of the individual risk and follow-up is carried out through specific action protocols.
The full details in Spanish can be found here and here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.